Share Facebook Twitter LinkedIn Pinterest Email Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 104% and 2.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
STMicroelectronics Announces Timing for Second Quarter 2022 Earnings Release and Conference CallJuly 6, 2022
APPlife’s ROOSTER ESSENTIALS, an E-Commerce Solution for Men’s Grooming Products Achieves 100% Quarterly Revenue GrowthJuly 6, 2022
